Skip to main content

Update for Primary Care Clinical Team 26 January 2023

 Public health and NHS topics discussed at our clinical meeting today at Dr Curran and Partners in Clapham, London.

1. Infectious diseases update

After high rates of infectious diseases such as Covid-19, influenza and Streptococcus A towards the end of 2022, we are seeing signs of falls in all these infections. This should help the NHS locally and nationally. However, Covid-19 remains a threat and it is very likely we will experience periods during 2023 when Covid-19 infections are high. 

a. Covid-19 statistics


b. Hospital admission rates in England: Covid-19 and influenza

c. Weekly scarlet fever notifications in England

2. New JCVI recommendations on Covid-19 vaccine boosters

The JCVI has recommended that Covid-19 booster vaccinations should be offered in the Spring and Autumn this year for selected groups of patients at high risk. In the Spring, this is likely to be similar to the programme in 2022 (i.e. the very elderly and immunocompromised). In the Autumn, it is likely to be similar to this Autumn’s programme but further details are awaited on eligibility. It is also likely that primary Covid-19 vaccinations will be stopped for people under 50 years not in a high-risk group. We need to encourage our unvaccinated patients in this group to come forwards for vaccination before this happens.

See https://www.gov.uk/government/publications/covid-19-vaccination-programme-for-2023-jcvi-interim-advice-8-november-2022/jcvi-statement-on-the-covid-19-vaccination-programme-for-2023-8-november-2022 for further details

 3. Vaccination in pregnancy

Recent research from my department has shown a low uptake of flu vaccination in pregnant women. Rates are also low for other vaccines such as Covid-19 and Pertussis. We need to consider how we improve vaccine uptake in this group.

See https://bjgp.org/content/early/2023/01/23/BJGP.2022.0078

 4. Practice vaccination programme

We need to think how we improve vaccine uptake in our patients as Lambeth is doing particularly badly for all vaccines. It may be possible to get some academic support to improve our delivery and uptake of NHS vaccines.

5. NHS pressures

Discussion about NHS primary care pressures and how the NHS GP contract could be modified. For example, an increase in activity-based funding or changes to the NHS to implement “core” (free) and “add-on” (payable) services. This would be controversial and risk increasing health inequalities.



Comments

Post a Comment

Popular posts from this blog

The Hidden Cost of Cheaper NHS Contracts: Losing Community Trust

NHS budgets are under considerable pressure. It is therefore unsurprising that many NHS Integrated Care Boards (ICBs) In England will aim to prioritise price in contract awards, But this approach is a significant threat to community-centred healthcare. While competitive tendering is a legally required, an excessive focus on costs in awarding NHS contracts risks overshadowing key factors such as established community trust, local expertise, and the long-term impact on continuity of care. This shift towards cheaper, often external, commercial providers threatens to cut the links between communities and their local health services. The argument that competitive tendering is solely about legal compliance, and not cost, is undermined by the very nature of such tendering, which by design encourages the lowest bid. This approach risks eroding the social fabric of local healthcare provision, where established relationships and understanding of specific community needs are essential. Establishe...
1 comment
Read more

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...
5 comments
Read more

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...
Post a Comment
Read more